F. Lerebours
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 4
- Oncology 20
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 7
- Cancer Risks and Factors 4
- Cancer Cells and Metastasis 3
- Co-authors
- Roman Rouzier (9 shared papers)Rosette Lidereau (3 shared papers)Marc Espié (3 shared papers)Anne Janin (1 shared paper)Anne de Roquancourt (2 shared papers)Philippe Bertheau (1 shared paper)François Plassa (1 shared paper)Michel M. Marty (1 shared paper)
- Journals
- Annals of Oncology (16 papers)British Journal of Cancer (4 papers)Breast Cancer Research and Treatment (2 papers)Oncogene (2 papers)The Lancet (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
F. Lerebours
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 484
- Oncology 616
- Pulmonary and Respiratory Medicine 239
- Molecular Biology 308
- Genetics 44
Countries citing papers authored by F. Lerebours
This map shows the geographic impact of F. Lerebours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lerebours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lerebours more than expected).
Fields of papers citing papers by F. Lerebours
This network shows the impact of papers produced by F. Lerebours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lerebours. The network helps show where F. Lerebours may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Lerebours, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 226 | |
| 2 | 2019 | 175 | |
| 3 | 2018 | 142 | |
| 4 | 2002 | 135 | |
| 5 | 2017 | 78 | |
| 6 | Regulation of Ras-related RhoB protein expression during the cell cycle. | 1995 | 70 |
| 7 | 2016 | 65 | |
| 8 | 2014 | 57 | |
| 9 | 2017 | 38 | |
| 10 | 2002 | 31 | |
| 11 | 2015 | 29 | |
| 12 | 2002 | 27 | |
| 13 | 2012 | 27 | |
| 14 | 2018 | 24 | |
| 15 | 2021 | 23 | |
| 16 | 2023 | 18 | |
| 17 | 2023 | 17 | |
| 18 | 2015 | 16 | |
| 19 | 2020 | 13 | |
| 20 | 2015 | 12 |
About F. Lerebours
F. Lerebours is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Family Practice and Molecular Biology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Risks and Factors (4 papers), Cancer Cells and Metastasis (3 papers) and Gene expression and cancer classification (3 papers). The work is most often cited by research in Cancer Research (484 citations), Oncology (616 citations), Pulmonary and Respiratory Medicine (239 citations), Molecular Biology (308 citations) and Genetics (44 citations). F. Lerebours has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Roman Rouzier, Rosette Lidereau, Marc Espié, Anne Janin, Anne de Roquancourt, Philippe Bertheau, François Plassa, Michel M. Marty, Yves Beuzard and E Turpin. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Breast Cancer Research and Treatment, Oncogene and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.